PhaseBio Pharmaceuticals EPS (Basic, Consolidated)

EPS (Basic, Consolidated) of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Basic, Consolidated) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Basic, Consolidated) for the quarter ending June 30, 2022 was -0.34 (a 47.88% increase compared to previous quarter)
  • Year-over-year quarterly EPS (Basic, Consolidated) decreased by -49.01%
  • Annual EPS (Basic, Consolidated) for 2021 was -2.98 (a -12.02% decrease from previous year)
  • Annual EPS (Basic, Consolidated) for 2020 was -3.39 (a 137.63% increase from previous year)
  • Annual EPS (Basic, Consolidated) for 2019 was -1.43 (a -68.24% decrease from previous year)
  • Twelve month EPS (Basic, Consolidated) ending June 30, 2022 was -2.08 (a -11.07% decrease compared to previous quarter)
  • Twelve month trailing EPS (Basic, Consolidated) decreased by -34.47% year-over-year
Trailing EPS (Basic, Consolidated) for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-2.08 -2.34 -2.98 -3.17
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Basic, Consolidated) of PhaseBio Pharmaceuticals

Most recent EPS (Basic, Consolidated)of PHAS including historical data for past 10 years.

Interactive Chart of EPS (Basic, Consolidated) of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals EPS (Basic, Consolidated) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.34 -0.23
2021 -0.85 -0.66 -0.6 -0.87 -2.98
2020 -1.04 -0.86 -0.98 -0.52 -3.39
2019 -0.4 -0.4 -0.33 -0.3 -1.43
2018 20.8 -10.45 -8.95 -5.9 -4.5
2017 -3.45 -13.79

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology